Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 144 (TMEM144) is a multi-pass membrane protein encoded by the *TMEM144* gene located on chromosome 4q32.1 in humans. Two protein isoforms exist, with the main isoform consisting of 345 amino acids (37.6 kDa). TMEM144 is predicted to function as a transmembrane transporter, likely for carbohydrates, although its precise molecular function remains unconfirmed. Expression is highest in adult brain tissue, particularly in oligodendrocytes and certain immune cells, with subcellular localization predictions including mitochondria, plasma membrane, endoplasmic reticulum, lysosome/vacuole, or Golgi apparatus. Clinically, high TMEM144 expression is a favorable prognostic biomarker in endometrial cancer but is associated with poorer prognosis in pancreatic cancer. No drugs that target TMEM144 are currently known, nor are there established mechanisms of action for potential modulators[1][4][9][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 144 (TMEM144).